Hwanin Pharm, 1Q Operating Profit 12 Billion KRW... 66% Increase YoY
[Asia Economy Reporter Ji Yeon-jin] Hwanin Pharmaceutical announced on the 28th that its consolidated sales in the first quarter increased by 7.6% year-on-year to 45.224 billion KRW, and operating profit rose by 66.7% to 12.074 billion KRW.
Hot Picks Today
"Even If I Lose My Investment, the Government Will Cover It"... The Fund Attracting Retail Investors' Attention [Weekend Money]
- AI Said to Eliminate Jobs, but This Role Sees 800% Surge in Hiring [Tech Talk]
- "One Person Bets 13.5 Billion Won to Have Lunch with the Investment Guru"
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
During this period, net profit increased by 55.4% to 9.924 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.